Abstract
A 67-year-old asymptomatic man with biochemical recurrent prostate cancer underwent F-fluciclovine PET/CT for restaging to determine subsequent treatment strategy. PET/CT images were obtained from the proximal thighs to the vertex of the skull, after the intravenous administration of 362.6 MBq (9.8 mCi) of F-fluciclovine. PET/CT imaging demonstrated a focus of abnormally increased F-fluciclovine uptake corresponding to a small nodularity in the left parotid gland. Subsequent ultrasound-guided fine-needle aspiration biopsy of the lesion revealed histopathology compatible with a benign Warthin tumor.
Original language | English (US) |
---|---|
Pages (from-to) | e208-e210 |
Journal | Clinical nuclear medicine |
Volume | 45 |
Issue number | 4 |
DOIs | |
State | Published - Apr 1 2020 |
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging